PR-21

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NamePR-21

Drug Alias NamePSA-NCAM mimotope (Pharmaxon)polysialylated form of the neural cell adhesion molecule mimotope (Pharmaxon)PR-21SPR-21PR-21C

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionNeural cell adhesion molecule 1 modulatorsNeuroprotectants

TargetsNeural cell adhesion molecule 1

Therapy Area/IndicationsCognition DisordersSpinal Cord Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPharmaxon

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPharmaxon

Active IndicationsN/A

Inactive IndicationsCognition DisordersSpinal Cord Injuries

ATC CodeN/A